First-line bevacizumab-containing therapy for breast cancer: results in patients aged≥70 years treated in the ATHENA study.
Ann Oncol
; 23(1): 111-118, 2012 Jan.
Article
in En
| MEDLINE
| ID: mdl-21444356
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Antibodies, Monoclonal, Humanized
Type of study:
Prognostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2012
Document type:
Article